In such cases, tumor inhibition was accompanied by an increased number of tumor-infiltrating leukocytes (CD3+ cells), reflecting that T cells were effectively recruited from the peripheral blood into the tumor bed to inhibit the growth of TfR-positive xenografts. This evidence concerns the gene TFRC and neoplasm.